BSTG - Biostage appoints Joseph Damasio as CFO August, 08 2022 05:08 PM Biostage Biostage ( OTC:BSTG ) said Monday it appointed Joseph Damasio as CFO . Damasio's recent experience includes CFO, VP finance and controller roles at Inhibikase Therapeutics, Cue Biopharma and Pressure Biosciences. For further details see: Biostage appoints Joseph Damasio as CFO